Boldenone (Equipose) is a veterinary injectable anabolic steroid, derivative of testosterone.
It exhibits strong androgenic and anabolic properties.
It is moderately aromatised to beta estradiol (E2) compared to nandrolone, therefore leading to less water retention.
However estrogenic side effects such as gynecomastia and body fat gain are noticed in doses above 400 mg per week.
As a derivative of testosterone, it suppresses the hypothalamic-pituitary-gonadal axis to a greater degree, compared to the DHT derivatives.
It stimulates appetite, vascularity and red bone marrow, increasing red blood cell production (erythropoietic effect).
As a result, boldenone increases the values of hematocrit (Htc), hemoglobin (Hgb) and myoglobin too.
It is a slow sustained release compound (undecylenate ester), which requires more than four weeks in order someone to observe any positive feedback.
Veterinary equipose is available in 50mg/ml; however a denser variety of boldenone is also available by underground laboratories at 200mg/ml.
BOLDENONE